Schedule 13D ownership disclosure

AEON BIOPHARMA INC

Class A Common Stock, $0.0001 par value per share · CUSIP: 00791X209

Event date: 2026-10-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Daewoong Co., Ltd.Reported CIK 0001985493

    Shares: 23,242,546.00 · Class: 30.6%

  • Daewoong Pharmaceutical Co., Ltd.

    Shares: 23,184,523.00 · Class: 30.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-26-117881
Form type
SCHEDULE 13D/A
Filer
Daewoong Co., Ltd
CIK
CIK 1985493
Filed
Nov 10, 2026
Reporting period
Oct 30, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub